Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab induction in kidney transplantation (tacrolimus-based regimen)
2005-001231-29Phase 3Active
- Sponsor
- Karolinska University Hospital
- Start
- Jul 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) comparing Rituximab induction arm with Placebo induction arm (2 arms). Primary endpoint: Composite treatment failure at 6 months. Started Jul 2005; status: active.
02
Drugs
rituximab
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2005-001231-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001231-29.